(NASDAQ: ASTH) Astrana Health's forecast annual revenue growth rate of 16.1% is forecast to beat the US Medical Care Facilities industry's average forecast revenue growth rate of 5.24%, and it is also forecast to beat the US market's average forecast revenue growth rate of 13.59%.
Astrana Health's revenue in 2026 is $2,896,455,000.On average, 13 Wall Street analysts forecast ASTH's revenue for 2026 to be $227,236,331,355, with the lowest ASTH revenue forecast at $196,671,722,010, and the highest ASTH revenue forecast at $246,486,969,285. On average, 8 Wall Street analysts forecast ASTH's revenue for 2027 to be $251,721,791,880, with the lowest ASTH revenue forecast at $214,402,572,735, and the highest ASTH revenue forecast at $270,916,141,395.
In 2028, ASTH is forecast to generate $242,940,799,140 in revenue, with the lowest revenue forecast at $233,371,768,590 and the highest revenue forecast at $250,089,427,845.